Cholesterol-Lowering Drugs Also May Protect Stem Cell Transplant Patients From A Potentially Deadly Complication

Cholesterol-lowering drugs known as statins are among the most prescribed medicines in the U.S. Now a new study by researchers at Fred Hutchinson Cancer Research Center indicates that statins may protect stem cell transplant patients from one of the most serious complications of the life-saving cancer therapy: graft-versus-host disease, or GVHD. The findings are reported in the Nov. 4 first edition of the journal Blood…

View post:
Cholesterol-Lowering Drugs Also May Protect Stem Cell Transplant Patients From A Potentially Deadly Complication

Related posts:

1. Advanced Leukemia Successfully Treated With First Use Of Antibody And Stem Cell Transplantation For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell...
2. "Mini" Transplant May Reverse Severe Sickle Cell Disease Results of a preliminary study by scientists at the National Institutes of Health and Johns Hopkins show that "mini" stem cell transplantation may safely reverse severe sickle cell disease in...
3. Study Could Point The Way To Drugs For Deadly Childhood Leukemia A new study could point the way to the development of better drugs to fight a deadly form of childhood leukemia called mixed-lineage leukemia (MLL). The study will help researchers...
4. Autologous Stem Cell Transplantation For Soft Tissue Sarcoma: Insufficient Research Into Therapy Due to a lack of suitable studies, it is unclear whether patients with soft tissue sarcoma can benefit from autologous haematopoietic stem cell transplantation. With this type of therapy, some...
5. Statins May Prevent Blood Clots In Patients With Cardiovascular Disease Statins may provide potentially life-saving benefits for patients with cardiovascular disease by helping reduce the incidence of blood clots....
6. Adult Stem Cells Safe, Promising In Treating Heart Attack Patients An FDA-approved clinical trial is the first to show that treating patients with adult stem cells after a heart attack is safe and that it appears to repair damaged heart...
7. Hebrew University, American Researchers Show Genetic ‘trigger’ To Stem Cell Differentiation A gene which is essential for stem cells' capabilities to become any cell type has been identified by researchers at the Hebrew University of Jerusalem and the University of California,...
8. Heart Disease In Kidney Transplant Patients May Be Caused By Sleep Apnea Sleep apnea is common in individuals who receive a kidney transplant and is associated with increased risk of high blood pressure, heart disease or stroke, according to a study appearing...
9. New Ethical Questions Are Being Raised In Stem Cell Research A groundbreaking discovery two years ago that turned ordinary skin cells back into an embryonic or "pluripotent" state was hailed as the solution to the controversial ethical question that has...
10. StemCells, Inc. Welcomes Approval Of First Embryonic Stem Cell Lines Under New NIH Guidelines StemCells, Inc. (NASDAQ: STEM) announced that it welcomes the approval yesterday by the National Institutes of Health (NIH) of the first 13 human embryonic stem cell (hESC) lines for use...
11. Ways of Lowering Cholesterol High cholesterol doesn't mean that you can't make efforts in lowering cholesterol naturally. Many people who find that their cholesterol is too high believe that they can only attain a...
12. Advanced Cell Technology Files IND With FDA For First Human Clinical Trial Using Embryonic Stem Cells To Treat Eye Disease Advanced Cell Technology, Inc. (OTCBB:ACTC) announced that it filed an Investigational New Drug (IND) Application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study...
13. Heart Transplant Patients Appear To Have Elevated Risk For Multiple Skin Cancers Many heart transplant patients develop multiple skin cancers, with increased risk for some skin cancers among patients with other cancers and with increasing age, according to a report in the...
14. COLD-FX(R) Maker Broadens Its Scientific Direction: Launches Pilot Trial Of New Formulation LIP-01 Geared To Lowering Cholesterol And Lipids Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) maker of COLD-FX announced the launch of a pilot clinical trial of a new formulation, LIP-01 that has shown promise in...
15. Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute’s 25th Anniversary Considered a highly risky and controversial medical procedure only 25 years ago, solid organ transplantation is now a life-saving mainstream operation thanks to the extraordinary men and women who gathered...

« Physician Offers Tips To Avoid Flu Infection Detox Diets and Detox Facts – Why YOU should Detox. »